<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="2aad9cdf-6431-4661-5cb4-f69e735f47e4"><labelDrug name="PLENDIL"><Normalization><mmtx cui="C0700021" preferredWord="Plendil" semType="phsu, orch"/></Normalization></labelDrug><generic name="Felodipine"/><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1" text="Drug Label for drug brand PLENDIL, containing Felodipine." type="negative"><entity charOffset="0:19" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand PLENDIL," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:33" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1.e.1" text="plendil" type="Biomedical_Entity"><Normalization><mmtx cui="C0700021" phraseText="Drug Label for drug brand PLENDIL," preferredWord="Plendil" semType="phsu, orch"/><RxNorm RxCui="203016"/></Normalization></entity><entity charOffset="46:56" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1.e.2" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="Felodipine." preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1.e.0" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1.e.1"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1.e.0" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1.e.2"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1.e.1" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.1.e.2"/></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.6" text="Hypotension Felodipine, like other calcium antagonists, may occasionally precipitate significant hypotension and, rarely, syncope. " type="negative"><entity charOffset="12:22" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.6.e.0" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="Hypotension Felodipine," preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="35:54" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.6.e.1" text="calcium antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0006684" phraseText="like other calcium antagonists," preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.6.e.0" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.6.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10" lineNumber="16" text="Caution, therefore, should be exercised when using PLENDIL in patients with heart failure or compromised ventricular function, particularly in combination with a beta blocker." type="regular"><entity charOffset="0:7" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.1" text="Caution" type="Caution_Interaction"/><entity charOffset="76:89" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.2" text="heart failure" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="with heart failure" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="with heart failure" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="93:125" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.3" text="compromised ventricular function" type="SPAN"/><entity charOffset="162:174" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.4" text="beta blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="with a beta blocker." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="51:58" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.5" text="PLENDIL" type="Drug"><Normalization><mmtx cui="C0700021" phraseText="PLENDIL in patients" preferredWord="Plendil" semType="phsu, orch"/><RxNorm RxCui="203016"/></Normalization></entity><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.1"><relations><relation type="hasContext"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.2, Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.3" ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.5" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.4" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.10.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.11" text="Patients with Impaired Liver Function Patients with impaired liver function may have elevated plasma concentrations of felodipine and may respond to lower doses of PLENDIL, therefore, a starting dose of 2.5 mg once a day is recommended. " type="negative"><entity charOffset="119:129" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.11.e.0" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="elevated plasma concentrations of felodipine" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="164:171" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.11.e.1" text="plendil" type="Biomedical_Entity"><Normalization><mmtx cui="C0700021" phraseText="doses of PLENDIL," preferredWord="Plendil" semType="phsu, orch"/><RxNorm RxCui="203016"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.11.e.0" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.11.e.1"/></sentence><sentence biomedicalEntities="7" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27" lineNumber="28" text="Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several-fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism. " type="regular"><entity charOffset="21:38" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1" text="CYP3A4 inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><entity charOffset="44:56" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.2" text="ketoconazole" type="Drug"><Normalization><mmtx cui="C0022625" phraseText="ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="58:70" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.4" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="72:84" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.6" text="erythromycin" type="Drug"><Normalization><mmtx cui="C0014806" phraseText="erythromycin," preferredWord="Erythromycin" semType="orch, antb"/><RxNorm RxCui="4053"/></Normalization></entity><entity charOffset="86:102" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.8" text="grapefruit juice" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="grapefruit juice," preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="104:114" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.10" text="cimetidine" type="Drug"><Normalization><mmtx cui="C0008783" phraseText="cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="157:187" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.12" text="increases in the plasma levels" type="Increase_Interaction"/><entity charOffset="191:201" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.13" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="increases in the plasma levels of felodipine," preferredWord="Felodipine" semType="phsu, orch"/><mmtx cui="C0015772" phraseText="increases in the plasma levels of felodipine," preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="220:247" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.15" text="increase in bioavailability" type="Increase_Interaction"/><entity charOffset="260:282" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.17" text="decrease in metabolism" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.2" drugClass="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1"/><drugClassMembership drug="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.4" drugClass="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1"/><drugClassMembership drug="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.6" drugClass="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1"/><drugClassMembership drug="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.10" drugClass="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1"/><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.12"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.13"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.ddi.2"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.15"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.13"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.ddi.3"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.17"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.13"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.13" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.12" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28" lineNumber="28" text="These increases in concentration may lead to increased effects, (lower blood pressure and increased heart rate). " type="irregular"><entity charOffset="65:85" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.1" text="lower blood pressure" type="Specific_Interaction"/><entity charOffset="90:110" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.3" text="increased heart rate" type="Specific_Interaction"/><entity charOffset="90:110" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.4" text="increased heart rate" type="SPAN"/><entity charOffset="65:85" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.5" text="lower blood pressure" type="SPAN"/><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27" text="Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several-fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism. "><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.13"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27" text="Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several-fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism. "><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.ddi.2"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27" text="Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several-fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism. "><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.13"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27" text="Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several-fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism. "><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29" lineNumber="28" text="These effects have been observed with co-administration of itraconazole (a potent CYP3A4 inhibitor). " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28" Text="These increases in concentration may lead to increased effects, (lower blood pressure and increased heart rate). "/><anaphoraEntity charOffset="0:13" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.1" text="These effects" type="Expression"/><antecedentEntity charOffset="90:110" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.3" text="increased heart rate" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28" Text="These increases in concentration may lead to increased effects, (lower blood pressure and increased heart rate). "/><anaphoraEntity charOffset="0:13" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.1" text="These effects" type="Expression"/><antecedentEntity charOffset="90:110" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.4" text="increased heart rate" type="SPAN"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28" Text="These increases in concentration may lead to increased effects, (lower blood pressure and increased heart rate). "/><anaphoraEntity charOffset="0:13" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.1" text="These effects" type="Expression"/><antecedentEntity charOffset="65:85" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.1" text="lower blood pressure" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28" Text="These increases in concentration may lead to increased effects, (lower blood pressure and increased heart rate). "/><anaphoraEntity charOffset="0:13" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.1" text="These effects" type="Expression"/><antecedentEntity charOffset="65:85" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28.e.5" text="lower blood pressure" type="SPAN"/></anaphoraRelation><entity charOffset="75:98" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.4" text="potent CYP3A4 inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="402226"/></Normalization></entity><entity charOffset="59:71" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.5" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="observed with co-administration of itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="0:13" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.7" text="These effects" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.5" drugClass="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.4"/><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.7"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27" text="Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several-fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism. "><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.27.e.13"/></ellipsisSentence><middleSentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.28" text="These increases in concentration may lead to increased effects, (lower blood pressure and increased heart rate). "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.29.e.5"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30" lineNumber="28" text="Caution should be used when CYP3A4 inhibitors are co-administered with felodipine. " type="regular"><entity charOffset="0:7" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.e.1" text="Caution" type="Caution_Interaction"/><entity charOffset="71:81" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.e.2" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="co-administered with felodipine." preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="28:45" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.e.3" text="CYP3A4 inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.e.3" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.e.2" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.30.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33" lineNumber="29" text="&lt;item&gt;Itraconazole Co-administration of another extended release formulation of felodipine with itraconazole resulted in approximately 8-fold increase in the AUC, more than 6-fold increase in the Cmax, and 2-fold prolongation in the half-life of felodipine." type="regular"><anaphoraRelation><anaphoraEntity charOffset="246:256" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.2" text="felodipine" type="Drug"/><antecedentEntity charOffset="48-90" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.9" text="extended release formulation of felodipine" type="Drug"/></anaphoraRelation><entity charOffset="142:161" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.1" text="increase in the AUC" type="Increase_Interaction"/><entity charOffset="246:256" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.2" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="2-fold prolongation in the half-life of felodipine." preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="96:108" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.3" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="with itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="180:200" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.5" text="increase in the Cmax" type="Increase_Interaction"/><entity charOffset="213:242" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.7" text="prolongation in the half-life" type="Increase_Interaction"/><entity charOffset="48:90" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.9" text="extended release formulation of felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="&gt;Itraconazole Co-administration of another extended release formulation of felodipine" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="284950"/></Normalization></entity><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.ddi.2"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.5"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.ddi.3"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.7"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.3" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.2" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.33.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34" lineNumber="30" text="&lt;item&gt;Erythromycin Co-administration of felodipine (PLENDIL) with erythromycin resulted in approximately 2.5-fold increase in the AUC and Cmax, and about 2-fold prolongation in the half-life of felodipine." type="regular"><entity charOffset="114:133" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.1" text="increase in the AUC" type="Increase_Interaction"/><entity charOffset="66:78" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.2" text="erythromycin" type="Drug"><Normalization><mmtx cui="C0014806" phraseText="with erythromycin" preferredWord="Erythromycin" semType="orch, antb"/><RxNorm RxCui="4053"/></Normalization></entity><entity charOffset="194:204" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.3" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="about 2-fold prolongation in the half-life of felodipine." preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="114:129|138:142" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.5" text="increase in the Cmax" type="Increase_Interaction"/><entity charOffset="161:190" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.7" text="prolongation in the half-life" type="Increase_Interaction"/><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.ddi.2"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.5"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.ddi.3"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.7"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.3" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.34.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35" lineNumber="31" text="&lt;item&gt;Grapefruit juice Co-administration of felodipine with grapefruit juice resulted in more than 2-fold increase in the AUC and Cmax, but no prolongation in the half-life of felodipine." type="regular"><entity charOffset="106:125" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.1" text="increase in the AUC" type="Increase_Interaction"/><entity charOffset="60:76" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.2" text="grapefruit juice" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="with grapefruit juice" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="176:186" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.3" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="no prolongation in the half-life of felodipine." preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="106:121|130:135" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.5" text="increase in the Cmax," type="Increase_Interaction"/><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.ddi.2"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.3" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.35.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36" lineNumber="32" text="&lt;item&gt;Cimetidine Co-administration of felodipine with cimetidine (a non-specific CYP-450 inhibitor) resulted in an increase of approximately 50% in the AUC and the Cmax, of felodipine." type="regular"><entity charOffset="68:98" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.1" text="non-specific CYP-450 inhibitor" type="Drug_Class"><Normalization><RxNorm RxCui="8895"/></Normalization></entity><entity charOffset="54:64" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.2" text="cimetidine" type="Drug"><Normalization><mmtx cui="C0008783" phraseText="with cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="115:123|145:155" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.4" text="increase in the AUC" type="Increase_Interaction"/><entity charOffset="173:183" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.5" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="of felodipine." preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="115:123|145:151|164:168" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.7" text="increase in the Cmax" type="Increase_Interaction"/><drugClassMembership drug="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.2" drugClass="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.1"/><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.4"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.ddi.2"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.7"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.5" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.36.e.4" type="Increase_Interaction"/></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37" text="&lt;item&gt;Beta-Blocking Agents A pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine. " type="negative"><entity charOffset="85:95" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.0" text="metoprolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0025859" phraseText="in conjunction with metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="159:169" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.1" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="no significant effects on the pharmacokinetics of felodipine." preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="54:64" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.2" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="A pharmacokinetic study of felodipine" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="6:26" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.3" text="beta-blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="&gt;Beta-Blocking Agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.0" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.1"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.0"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.3" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.0"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.3" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.1"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.3" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38" lineNumber="33" text="The AUC and Cmax of metoprolol, however, were increased approximately 31 and 38%, respectively. " type="irregular"><entity charOffset="4:7|46:55" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38.e.1" text="AUC increased" type="Increase_Interaction"/><entity charOffset="20:30" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38.e.2" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="Cmax of metoprolol," preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="12:16|46:55" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38.e.4" text="Cmax increased" type="Increase_Interaction"/><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37" text="&lt;item&gt;Beta-Blocking Agents A pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine. "><entity charOffset="159:169" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.0" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="no significant effects on the pharmacokinetics of felodipine." preferredWord="Felodipine" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38.ddi.2"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38.e.4"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37" text="&lt;item&gt;Beta-Blocking Agents A pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine. "><entity charOffset="159:169" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.37.e.0" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="no significant effects on the pharmacokinetics of felodipine." preferredWord="Felodipine" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.38.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39" text="In controlled clinical trials, however, beta blockers including metoprolol were concurrently administered with felodipine and were well tolerated." type="negative"><entity charOffset="111:121" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39.e.0" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="administered with felodipine" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="64:74" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39.e.1" text="metoprolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0025859" phraseText="metoprolol" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><entity charOffset="40:53" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39.e.2" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39.e.1" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39.e.0"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39.e.0"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.39.e.1"/></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.40" text="&lt;item&gt;Digoxin When given concomitantly with PLENDIL the pharmacokinetics of digoxin in patients with heart failure were not significantly altered." type="negative"><entity charOffset="44:51" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.40.e.0" text="plendil" type="Biomedical_Entity"><Normalization><mmtx cui="C0700021" phraseText="concomitantly with PLENDIL" preferredWord="Plendil" semType="phsu, orch"/><RxNorm RxCui="203016"/></Normalization></entity><entity charOffset="76:83" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.40.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="the pharmacokinetics of digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="6:13" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.40.e.2" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="&gt;Digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.40.e.0" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.40.e.1"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.40.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.40.e.0"/></sentence><sentence biomedicalEntities="5" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41" lineNumber="35" text="&lt;item&gt;Anticonvulsants In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, phenytoin, carbamazepine, or phenobarbital) than in healthy volunteers. " type="regular"><entity charOffset="50:79|112:119" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.1" text="maximum plasma concentrations lower i" type="Decrease_Interaction"/><entity charOffset="83:93" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.2" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="maximum plasma concentrations of felodipine" preferredWord="Felodipine" semType="phsu, orch"/><mmtx cui="C0015772" phraseText="maximum plasma concentrations of felodipine" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="153:167" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.3" text="anticonvulsant" type="Drug_Class"><Normalization><mmtx cui="C0003286" phraseText="on long-term anticonvulsant therapy" preferredWord="Anticonvulsants" semType="phsu"/><RxNorm RxCui="926"/></Normalization></entity><entity charOffset="121:139" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.4" text="epileptic patients" type="SPAN"><Normalization><mmtx cui="C0014544" phraseText="considerably lower in epileptic patients" preferredWord="Epilepsy" semType="dsyn"/></Normalization></entity><entity charOffset="181:190" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.6" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="phenytoin," preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="192:205" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.8" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine," preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><entity charOffset="210:223" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.10" text="phenobarbital" type="Drug"><Normalization><mmtx cui="C0031412" phraseText="phenobarbital" preferredWord="Phenobarbital" semType="phsu, orch"/><RxNorm RxCui="8134"/></Normalization></entity><drugClassMembership drug="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.6" drugClass="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.3"/><drugClassMembership drug="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.8" drugClass="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.3"/><drugClassMembership drug="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.10" drugClass="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.3"/><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.4" ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.3" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.42" lineNumber="35" text="In such patients, the mean area under the felodipine plasma concentration-time curve was also reduced to approximately 6% of that observed in healthy volunteers. " type="irregular"><entity charOffset="18:41|53:101" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.42.e.1" text="the mean area under the plasma concentration-time curve was also reduced" type="Decrease_Interaction"/><entity charOffset="42:52" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.42.e.2" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="the mean area under the felodipine plasma concentration-time curve" preferredWord="Felodipine" semType="phsu, orch"/><mmtx cui="C0015772" phraseText="the mean area under the felodipine plasma concentration-time curve" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.42.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.42.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41" text="&lt;item&gt;Anticonvulsants In a pharmacokinetic study, maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy (eg, phenytoin, carbamazepine, or phenobarbital) than in healthy volunteers. "><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.41.e.3"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.42.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44" lineNumber="36" text="&lt;item&gt;Tacrolimus Felodipine may increase the blood concentration of tacrolimus. " type="regular"><entity charOffset="32:64" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.e.1" text="increase the blood concentration" type="Increase_Interaction"/><entity charOffset="68:78" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.e.2" text="tacrolimus" type="Drug"><Normalization><mmtx cui="C0085149" phraseText="the blood concentration of tacrolimus." preferredWord="Tacrolimus" semType="phsu, orch"/><mmtx cui="C0085149" phraseText="the blood concentration of tacrolimus." preferredWord="Tacrolimus" semType="phsu, orch"/><RxNorm RxCui="42316"/></Normalization></entity><entity charOffset="17:27" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.e.3" text="Felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="&gt;Tacrolimus Felodipine" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.e.3" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.e.2" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.44.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45" lineNumber="36" text="When given concomitantly with felodipine, the tacrolimus blood concentration should be followed and the tacrolimus dose may need to be adjusted." type="regular"><entity charOffset="87:95" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.1" text="followed" type="Caution_Interaction"/><entity charOffset="30:40" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.2" text="felodipine" type="Drug"><Normalization><mmtx cui="C0015772" phraseText="concomitantly with felodipine," preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="46:56" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.3" text="tacrolimus" type="Drug"><Normalization><mmtx cui="C0085149" phraseText="the tacrolimus blood concentration" preferredWord="Tacrolimus" semType="phsu, orch"/><mmtx cui="C0085149" phraseText="the tacrolimus blood concentration" preferredWord="Tacrolimus" semType="phsu, orch"/><RxNorm RxCui="42316"/></Normalization></entity><entity charOffset="115:143" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.5" text="dose may need to be adjusted" type="Caution_Interaction"/><entity charOffset="104:114" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.6" text="tacrolimus" type="Drug"><Normalization><mmtx cui="C0085149" phraseText="the tacrolimus dose" preferredWord="Tacrolimus" semType="phsu, orch"/><RxNorm RxCui="42316"/></Normalization></entity><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.ddi.1"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.ddi.2"><interaction trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.5"><relations><relation type="hasObject"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.3" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.6" trigger="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.45.e.5" type="Caution_Interaction"/></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46" text="&lt;item&gt;Other Concomitant Therapy In healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone." type="negative"><entity charOffset="163:177" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46.e.0" text="spironolactone" type="Biomedical_Entity"><Normalization><mmtx cui="C0037982" phraseText="spironolactone." preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="147:159" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46.e.1" text="indomethacin" type="Biomedical_Entity"><Normalization><mmtx cui="C0021246" phraseText="concomitantly with indomethacin" preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><entity charOffset="107:117" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46.e.2" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="felodipine" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46.e.1" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46.e.0"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46.e.0"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.46.e.1"/></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.49" text="In a 2-year carcinogenicity study in rats fed felodipine at doses of 7.7, 23.1 or 69.3 mg/kg/day (up to 61 times Based on patient weight of 50 kg the maximum recommended human dose on a mg/m2 basis), a dose-related increase in the incidence of benign interstitial cell tumors of the testes (Leydig cell tumors) was observed in treated male rats. " type="negative"><entity charOffset="192:197" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.49.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="human dose on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="46:56" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.49.e.1" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="felodipine at doses of 7.7," preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.49.e.1" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.49.e.0"/></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51" text="Felodipine, at the doses employed in the 2-year rat study, has been shown to lower testicular testosterone and to produce a corresponding increase in serum luteinizing hormone in rats. " type="negative"><entity charOffset="156:175" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51.e.0" text="luteinizing hormone" type="Biomedical_Entity"><Normalization><mmtx cui="C0023607" phraseText="a corresponding increase in serum luteinizing hormone" preferredWord="Luteinizing Hormone" semType="phsu, aapp, horm"/><RxNorm RxCui="6383"/></Normalization></entity><entity charOffset="94:106" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51.e.1" text="testosterone" type="Biomedical_Entity"><Normalization><mmtx cui="C0039601" phraseText="testicular testosterone" preferredWord="Testosterone" semType="strd, phsu, horm"/><RxNorm RxCui="10382"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51.e.2" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="Felodipine," preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51.e.1" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51.e.0"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51.e.0"/><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51.e.2" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.51.e.1"/></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.56" text="Felodipine was not carcinogenic when fed to mice at doses up to 138.6 mg/kg/day (61 times1 the maximum recommended human dose on a mg/m2 basis) for periods of up to 80 weeks in males and 99 weeks in females." type="negative"><entity charOffset="0:10" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.56.e.0" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="Felodipine" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="137:142" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.56.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="human dose on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.56.e.0" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.56.e.1"/></sentence><sentence id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.59" text="A fertility study in which male and female rats were administered doses of 3.8, 9.6 or 26.9 mg/kg/day (up to 24 times1 the maximum recommended human dose on a mg/m2 basis) showed no significant effect of felodipine on reproductive performance." type="negative"><entity charOffset="204:214" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.59.e.0" text="felodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0015772" phraseText="no significant effect of felodipine" preferredWord="Felodipine" semType="phsu, orch"/><RxNorm RxCui="4316"/></Normalization></entity><entity charOffset="165:170" id="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.59.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="human dose on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.59.e.1" e2="Dailymed.2aad9cdf-6431-4661-5cb4-f69e735f47e4.s.59.e.0"/></sentence><positiveExamples number="12"/><negativeExamples number="24"/></document>